Reumatologia最新文献

{"title":"Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder.","authors":"Ciro Manzo, Arvind Nune","doi":"10.5114/reum.2023.124336","DOIUrl":"https://doi.org/10.5114/reum.2023.124336","url":null,"abstract":"Polymyalgia rheumatica (PMR) is one of the most common inflammatory rheumatic disease affecting the elderly [1]. Up to 20% of patients with PMR may develop giant cell arteritis (GCA), a primary granulomatous vasculitis affecting the aorta and its branches. The association of PMR with GCA, also known as “Horton’s disease”, has therapeutic and prognostic consequences [2]. The possibility that isolated PMR can be a paraneoplastic syndrome has long been debated with conflicting viewpoints. Some points should be pondered.","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/9c/RU-61-156698.PMC10044035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9225975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subclinical retinopathy in systemic lupus erythematosus patients - optical coherence tomography study.","authors":"Małgorzata Karolina Mimier-Janczak,&nbsp;Dorota Kaczmarek,&nbsp;Krzysztof Proc,&nbsp;Marta Misiuk-Hojło,&nbsp;Radosław Kaczmarek","doi":"10.5114/reum/166296","DOIUrl":"https://doi.org/10.5114/reum/166296","url":null,"abstract":"<p><strong>Introduction: </strong>The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to assess the relationship between OCT parameters and disease activity, therapy type and burden on other organs to demonstrate the utility of OCT in early retinal impairment in SLE patients.</p><p><strong>Material and methods: </strong>Cross-sectional study. Thirty-three SLE patients (57 eyes) and 31 healthy individuals (56 eyes) were enrolled in the study. We excluded patients with evidence of lupus retinopathy or hydroxychloroquine (HCQ) toxicity on OCT or fundus examination to reveal any subclinical changes. All patients underwent full ophthalmologic examination in the slit lamp including best corrected visual acuity, tonometry, and OCT. The Kolmogorov-Smirnov distribution test was used to assess the normal distribution in quantitative values. The differences between the individual measured parameters in the groups were analyzed using the Mann-Whitney <i>U</i> test. Spearman's rank correlation test was used to assess the correlation between the measured parameters and quantitative clinical data.</p><p><strong>Results: </strong>There was no difference in the OCT findings between SLE and healthy control groups. Among the study group a negative correlation was found between disease duration and age and retinal nerve fiber layer thickness in the inferior quadrant (<i>p</i> = 0.0063, <i>p</i> = 0.0036). No correlations were observed between examined retinal parameters and duration of hydroxychloroquine therapy, hydroxychloroquine as well as chloroquine cumulative dose and disease activity indices.</p><p><strong>Conclusions: </strong>Optical coherence tomography is a widespread ophthalmic modality used for SLE retinopathy and HCQ toxicity screening. Our study did not demonstrate its clinical potency in diagnosis of subclinical retinal involvement. An optical coherence tomography device seems to be less sensitive in subclinical retinal impairment detection than optical coherence tomography angiography.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 3","pages":"161-168"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/51/RU-61-166296.PMC10373166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9913638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.","authors":"Agnieszka Trybuch,&nbsp;Beata Tarnacka","doi":"10.5114/reum/168362","DOIUrl":"10.5114/reum/168362","url":null,"abstract":"<p><p>Polymyositis (PM) and dermatomyositis (DM) are rare idiopathic inflammatory myopathies (IIM). Myocardial involvement in patients with IIM is an unfavorable prognostic factor and one of the most common cause of mortality in this group of patients. The purpose of this review is to present current knowledge on cardiovascular manifestations observed in IIM. Data published in English until December 2021 were selected. Clinical symptoms suggesting cardiac involvement are non-specific and require a differential diagnosis in accordance with cardiological guidelines. Troponin I is specific to cardiac injury and should be preferred to other markers to evaluate the myocardium in IIM. Abnormalities in electrocardiography are common in IIM, especially non-specific changes of the ST-T segment. In standard echocardiography left ventricular diastolic dysfunction is reported frequently. New diagnostic technologies can reveal clinically silent myocardial abnormalities. However, the prognostic value of subclinical impairment of myocardial function require further studies.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 3","pages":"202-212"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/48/RU-61-168362.PMC10373167.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9913642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influenza - a problem still existing during the COVID-19 pandemic.","authors":"Lidia B Brydak","doi":"10.5114/reum/169416","DOIUrl":"https://doi.org/10.5114/reum/169416","url":null,"abstract":"Address for correspondence: Lidia B. Brydak, National Institute of Public Health – National Research Institute, 24 Chocimska St., 00-791 Warsaw, Poland, e-mail: lbrydak@pzh.gov.pl Submitted: 29.04.2023; Accepted: 12.05.2023 Influenza has always been and will be in years to come a global and public health problem. Therefore the improvement and expansion of the Global Influenza Surveillance and Response System (GISRS) should be a priority for the healthcare community [1]. In 1947, at the 4th International Congress of Microbiologists in Copenhagen, the World Health Organization (WHO) foundations were laid for the future GISRS (which was finally created in 1952 and in 2022 celebrated its 70th anniversary) with the establishment of the first seven WHO Collaborating Centers for Reference and Research on Influenza in their current form. Since 1957 Poland has been participating in this system for monitoring influenza, as one of 149 National Influenza Centers worldwide. Poland was responsible for the introduction of the SENTINEL surveillance methods during its leadership of GISRS in the 2004/2005 epidemic season [2]. Virological data obtained by the Collaborating Centers for Reference and Research on Influenza are reported to the WHO and the European Union Agency: European Centre for Disease Prevention and Control (ECDC) [3]. As an example of such data, the information provided to the WHO by Poland concerning epidemic seasons from 2015/2016 to 2022/2023, including the time when the COVID-19 pandemic took place, is presented in Table I. On March 11, 2020, the WHO announced the COVID-19 pandemic. As shown in Table I, the values of all the indicators used for influenza monitoring were definitely lower at the time of the pandemic. This phenomenon is attributed to the fact that a significant part of the population worked remotely, including schools and universities, and mandates to wear masks were introduced to avoid the transmission of respiratory infections. The number of deaths resulting from post-influenza complications reported in Poland is underestimated – which is true not only in the case of data presented in Table I, as some deaths are attributed to the wrong disease entity. In the 2021/2022 epidemic season, i.e. from October 1, 2021 to September 30, 2022, a total of 2,317 samples","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 3","pages":"149-151"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/cc/RU-61-169416.PMC10373163.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9913645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Life satisfaction, generalized sense of self-efficacy and acceptance of illness in rheumatoid arthritis patients depending on age and severity of the disease.","authors":"Magdalena Staszkiewicz,&nbsp;Małgorzata Kulesa-Mrowiecka,&nbsp;Joanna Szklarczyk,&nbsp;Jolanta Jaworek","doi":"10.5114/reum/168294","DOIUrl":"https://doi.org/10.5114/reum/168294","url":null,"abstract":"<p><strong>Introduction: </strong>Rheumatoid arthritis (RA) is a chronic autoimmune condition characterized by periods of exacerbation (physical limitations, depressed mood, depressive states and decreased life satisfaction) and remission (hope of health improvement). Our objective was to present social functioning of RA patients taking into consideration their age and employing selected determinants: satisfaction with life, generalized sense of self-efficacy and acceptance of illness.</p><p><strong>Material and methods: </strong>Standardized tools were employed: the Satisfaction with Life Scale, Generalized Self Efficacy Scale and Acceptance of Illness Scale. The study group included 46 RA patients aged 18-45 years and 54 RA patients aged over 60 years. The control group consisted of 24 non-RA subjects in every group.</p><p><strong>Results: </strong>Rheumatoid arthritis patients in the period of disease exacerbation reported low and moderate levels of satisfaction with life, in the patients in remission period the score was moderate, while the control group subjects described their level of satisfaction with life as high and moderate. The level of acceptance of illness was described by the RA patients in the period of disease exacerbation as 20.4/40 points; the patients in remission defined their level of acceptance of illness as 29.38/40 points. The patients with RA exacerbation showed a low sense of self-efficacy, yet a large group of such patients also presented high self-efficacy levels and the majority of the RA subjects in remission reported a high sense of self-efficacy.</p><p><strong>Conclusions: </strong>In the RA patients, satisfaction with life, generalized sense of self-efficacy and acceptance of illness were closely related and affected their general psychosocial functioning.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 3","pages":"175-185"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/85/RU-61-168294.PMC10373164.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10286346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The prevalence and correlation of depression and anxiety with disease activity in rheumatoid arthritis.","authors":"Sousan Moudi,&nbsp;Behzad Heidari,&nbsp;Behnaz Yousefghahari,&nbsp;Reza Gholami,&nbsp;Hemmat Gholinia,&nbsp;Mansour Babaei","doi":"10.5114/reum/154905","DOIUrl":"https://doi.org/10.5114/reum/154905","url":null,"abstract":"<p><strong>Introduction: </strong>Depression and anxiety share similar symptoms with rheumatoid arthritis (RA) and these conditions are often not diagnosed or overlooked in RA. This study aimed to determine the prevalence of depression/anxiety in RA and their correlation with RA activity.</p><p><strong>Material and methods: </strong>Rheumatoid arthritis patients who presented at a rheumatology clinic were selected consecutively. The diagnosis of RA was confirmed by the ACR/EULAR criteria, disease activity was assessed by Disease Activity Score based on the 28-joint count (DAS28) and patients with DAS28 > 2.6 were considered to have active RA. The diagnosis of depression and anxiety was made by the Hospital Anxiety and Depression Scale (HADS). The Pearson test was used to determine the correlation between DAS28 and HADS scores.</p><p><strong>Results: </strong>Two-hundred patients (female, 82%) with a mean age of 53.5 ±10.1 years and mean disease duration of 6.6 ±6.8 years were studied. Depression was diagnosed in 27 (13.5%) patients and anxiety in 38 (19%) patients. The DAS28 score correlated positively with depression (<i>r</i> = 0.173, <i>p</i> = 0.014) and anxiety score (<i>r</i> = 0.229, <i>p</i> = 0.001). In multiple logistic regression analysis after adjustment for all covariates, age < 40 years and female sex were independently associated with RA activity in patients with depression, with OR = 4.21 (<i>p</i> = 0.002) and OR = 3.56 (<i>p</i> = 0.028) respectively.</p><p><strong>Conclusions: </strong>These findings indicate that depression and anxiety are prevalent in RA and correlate positively with active disease in particular in depressive female patients aged < 40 years.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 2","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/6d/RU-61-154905.PMC10201383.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9510011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of antiresorptive agents on body composition: a case-control retrospective study.","authors":"Suhel Gabriele Al Khayyat,&nbsp;Giuseppe Fogliame,&nbsp;Edoardo Conticini,&nbsp;Virginia Berlengiero,&nbsp;Paolo Falsetti,&nbsp;Stefano Gentileschi,&nbsp;Caterina Baldi,&nbsp;Marco Bardelli,&nbsp;Luca Cantarini,&nbsp;Bruno Frediani","doi":"10.5114/reum.2023.124335","DOIUrl":"https://doi.org/10.5114/reum.2023.124335","url":null,"abstract":"<p><strong>Introduction: </strong>Osteoporosis is the most represented metabolic bone disease and is characterized by the reduction of bone mineral density (BMD), exposing patients to high fracture risk and disability. Bisphosphonates (BPs) are the main compounds exploited in treatment of osteoporosis and significantly reduce fracture risk. Sarcopenia is the pathological reduction of muscle masses and strength, and many studies highlighted its co-existence in patients with impaired bone mass. Indeed, the pathological reduction of lean tissue has been linked to a higher risk of falls and, consequently, fractures and disability. Moreover, the pathological reduction of lean tissue seems to share many pathological mechanisms with impaired bone strength and structure; thus, in this context, we decided to conduct a retrospective case-control study aimed at evaluating the effects of BPs on lean mass and body composition.</p><p><strong>Material and methods: </strong>We enrolled postmenopausal women from our metabolic bone diseases outpatient clinic who underwent at least two consecutive dual-energy X-ray absorptiometry (DXA) examinations concomitantly to the beginning of an antiresorptive agent. The body composition of patients and controls was compared by fat masses, lean masses and android-to-gynoid ratio (A/G ratio).</p><p><strong>Results: </strong>A total of 64 female subjects were considered for the study: 41 starting a BPs and 23 without treatment were used as control. The fat masses and lean masses appeared to be unaffected by BPs. Conversely, A/G ratio was lower in BPs group after 18 months of therapy compared to baseline (<i>p</i> < 0.05). From the stratification based on the single BP we failed to highlight any significant difference between the tested variables.</p><p><strong>Conclusions: </strong>Bisphosphonates treatment did not modify lean tissues, however a significant reduction of A/G ratio in BP group was documented. Thus the BPs seems to act on patients body composition and extra-skeletal tissues but larger prospective studies are needed to evaluate whether these modifications have clinical relevance.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 2","pages":"92-96"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/02/2c/RU-61-156907.PMC10201384.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9521982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Osteoporosis and diabetes - possible links and diagnostic difficulties.","authors":"Joanna Magdalena Tomasiuk,&nbsp;Anna Nowakowska-Płaza,&nbsp;Małgorzata Wisłowska,&nbsp;Piotr Głuszko","doi":"10.5114/reum/170048","DOIUrl":"https://doi.org/10.5114/reum/170048","url":null,"abstract":"<p><strong>Objectives: </strong>In this review, the authors aimed to clarify the relationship between the occurrence of osteoporosis and diabetes, analyze the differences between the pathogenesis of osteoporosis in different types of diabetes and propose the most effective diagnostic strategy and fracture risk assessment in diabetic patients.</p><p><strong>Material and methods: </strong>A analysis of publications in MEDLINE, COCHRANE and SCOPUS databases was performed, searching for reports on the diagnostics, fracture risk assessment, prevention, and treatment of osteoporosis in patients with diabetes mellitus (DM) published in the years 2016-2022. The key words for the search were: diabetes, osteoporosis, and low-energy fracture.</p><p><strong>Results: </strong>Bone complications of T1DM are more severe than T2DM, because of the lack of anabolic effect of insulin on bones. In T2DM the risk of fractures is elevated; however, identifying the mechanisms underlying the increased risk of fractures in T2DM is not clear. The FRAX tool is not appropriate for assessing the fracture risk in young patients with T1DM. It is quite useful in older patients with T2DM, but in these patients the calculated fracture risk may be underestimated. In T2DM the fracture risk often does not correspond to BMD value as measured by dual-energy X-ray absorptiometry (DXA). Diagnostic tools such as the trabecular bone score may play a significant role in this group of patients. Conclusions: Optimal strategies to identify and treat high risk individuals require further research and proper definition. The diagnostic criteria for osteoporosis should be clearly defined as well as fracture risk assessment and choice of anti-osteoporotic medication. In all cases of secondary osteoporosis, treatment of the underlying disease is the most important. The relationship between high risk of fractures and diabetes is inseparable, and its full understanding seems to be the key to effective management.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 4","pages":"294-304"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/ba/RU-61-170048.PMC10515121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41134723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update.","authors":"Ciro Manzo, Alberto Castagna, Arvind Nune, Marco Isetta","doi":"10.5114/reum/172508","DOIUrl":"https://doi.org/10.5114/reum/172508","url":null,"abstract":"","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 5","pages":"408-409"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134649591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Peculiarities of clinical signs, course and treatment of musculoskeletal system lesions in post-COVID syndrome.","authors":"Larysa Voloshyna, Svitlana Smiyan, Oleksandr Voloshyn, Inna Buzdugan, Olga Bukach, Natalia Voloshynovych, Oleksandra Doholich","doi":"10.5114/reum/172575","DOIUrl":"10.5114/reum/172575","url":null,"abstract":"<p><strong>Introduction: </strong>Post-COVID syndrome (PCS) is a frequent phenomenon of patients who have suffered from an acute attack of COVID-19 infection, and it is characterized by a wide range of symptoms from different organs and systems including the musculoskeletal system (MSS). However, peculiarities of MSS lesions have not been sufficiently studied to date, in particular, in the aspect of the therapeutic process. We aimed to investigate peculiarities of MSS lesions in patients with PCS.</p><p><strong>Material and methods: </strong>Observations were carried out in 142 patients with PCS and MSS lesions. The age of patients was 36-67 years. Up-to-date methods of disease verification were used. An acute period of COVID-19 in all the patients was of moderate severity without oxygen support.</p><p><strong>Results: </strong>Musculoskeletal system lesions in patients with PCS were found to appear 1-4 weeks after the experienced acute period of COVID-19 infection. Against the background of significant arthralgia (100%) in 93 (65.5%) patients manifestations of acute arthritis were detected, the frequency of which increased with age. Musculoskeletal system lesions were found against the background of dominating PCS manifestations from the cardiovascular and digestive systems. Deterioration of the course and results of treatment of diseases caused by an age-related polymorbid background was determined. Certain difficulties in the treatment of MSS lesions by means of non-steroidal anti-inflammatory drugs and limitation in the use of glucocorticosteroids are caused by severe gastroduodenopathy and arterial hypertension. Long-term, up to 6 months, administration of L-arginine, L-carnitine and quercetin in the rehabilitation complex improved the overall results of treatment of PCS manifestations including arthropathy.</p><p><strong>Conclusions: </strong>Musculoskeletal system lesions in patients with PCS are not the main constituent of this syndrome. Difficulties in the treatment of arthropathy are due to the signs of gastroduodenopathy and arterial hypertension. Additional administration of L-arginine, L-carnitine and quercetin is reasonable.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":"61 5","pages":"339-344"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134649590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}